SCHEDULE: Bank of America Reports 3.5% Stake in Outset Medical

Bank of America Corporation has disclosed a beneficial ownership of 666,596 shares, representing 3.5% of the outstanding common stock of Outset Medical, Inc.

Summary

• Bank of America Corporation, through its subsidiaries, has filed a Schedule 13G, indicating it beneficially owns 666,596 shares of Outset Medical, Inc. common stock.
• This ownership stake represents 3.5% of the total outstanding shares.
• The filing is an amendment (Amendment No. 1) and the event date requiring the filing is June 30, 2026.
• The beneficial ownership calculation is based on 18,797,000 outstanding shares as of June 30, 2026, as reported by Outset Medical in its Form 10-Q filed on August 6, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting routine ownership changes and not containing significant new strategic or financial information.

Positives

• Bank of America's filing confirms a significant institutional investor's stake, which can be seen as a vote of confidence in the company's long-term prospects.
• The clear disclosure of ownership percentage (3.5%) provides transparency for other investors.

Negatives

• The filing does not contain any new financial performance data or strategic initiatives from Outset Medical, Inc. itself.
• The ownership is reported as shared for both voting and dispositive power, indicating potential influence from multiple Bank of America entities.

Risks

• Potential for future changes in Bank of America's stake, which could impact Outset Medical's stock price.
• The filing does not provide insights into the specific investment strategy or rationale behind Bank of America's ownership.

Future Outlook

This filing is a snapshot of ownership as of a specific date and does not contain forward-looking statements or guidance from Outset Medical, Inc. or Bank of America regarding future performance or strategy.

Management Comments

• "The beneficial ownership calculation relies on the 18,797,000 outstanding shares disclosed in the Form 10-Q by the issuer on August 6, 2026, which reports share totals as of June 30, 2026."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that large financial institutions like Bank of America frequently file Schedule 13G or 13D forms to report significant ownership stakes in publicly traded companies. This filing indicates Bank of America's role as a substantial, though not controlling, shareholder in the medical technology sector.

Comparison to Industry Standards

• Reporting of beneficial ownership by large financial institutions is standard practice under SEC regulations.
• A 3.5% stake is a common threshold for institutional investors to report, often signifying a passive investment strategy unless a 13D filing is made.
• The specific entities within Bank of America (BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, Merrill Lynch Pierce Fenner & Smith, Inc.) are typical operating subsidiaries involved in such investments.

Stakeholder Impact

• Shareholders: Increased transparency regarding institutional ownership, potentially influencing investor sentiment.
• Creditors: No direct impact indicated, as the filing pertains to equity ownership.
• Employees: No direct impact indicated.
• Suppliers/Customers: No direct impact indicated.

Next Steps

• Continued monitoring of Outset Medical, Inc.'s financial performance and strategic developments.
• Observation of any future changes in Bank of America's ownership stake.

Key Dates

Keywords

Outset Medical, Bank of America, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Ownership Stake